Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
Beta Bionics (Nasdaq: BBNX) will release its first quarter 2026 financial results after markets close on April 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Beta Bionics (Nasdaq: BBNX) will release its first quarter 2026 financial results after markets close on April 21, 2026. Management will host a conference call and concurrent webcast the same day at 4:30 PM ET (1:30 PM PT) to review Q1 2026 performance.
The live webcast link and archived replay will be available in the Investors & Events section at the company website, and phone access requires registration for dial-in details and a personal PIN.
Details
News Market Reaction – BBNX
On Mar 31, the first trading day after this news, BBNX closed 1.62% above the previous close.
Data tracked by StockTitan Argus for the Mar 31 session.
Key Figures
- Earnings release date
- April 21, 2026
- First quarter 2026 financial results release after market close
- Conference call time
- 4:30 pm ET
- Management call to review Q1 2026 performance
- Conference call time PT
- 1:30 pm PT
- Corresponding Pacific Time for Q1 2026 call
- Quarter referenced
- First quarter 2026
- Upcoming financial results to be reported
Historical Context
-
Announced TD Cowen healthcare conference presentation with webcast access.
-
Reported strong 2025 growth and introduced 2026 revenue and margin guidance.
-
Released preliminary Q4 2025 topline financial results and key operating metrics.
-
Planned pre-release of Q4 2025 topline results and investor meetings schedule.
-
Outlined participation in two upcoming healthcare investor conferences with webcasts.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2026 financial results after the financial markets close on Tuesday, April 21, 2026. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to review the company’s first quarter 2026 performance.
The link to the webcast will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use the following link, which will provide you with dial-in details and a personal pin: https://register-conf.media-server.com/register/BIe6169095850a4ded9529fe8fccd41156
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Felicia Sanborn
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.